TP53 and neoplasm: EBV-negative tumours usually have a mutation in the p53 pathway (TP53, USP7 or CDKN2A mutation in 75% of cases) that overcomes this tendency to undergo apoptosis, but these occur in only 30% of EBV-positive BL [40].